— Know what they know.
Not Investment Advice

LNDC NASDAQ

Landec Corporation
1W: -3.0% 1M: +7.1% 3M: -24.2% 1Y: -7.9% 3Y: -19.5% 5Y: -28.5%
$8.76
Last traded 2022-11-14 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $263.6M mcap · 20M float · 0.327% daily turnover

📊 Key Metrics

TTM
$125M
Revenue
+39.9% YoY
$-32M
Net Income
-326.1% YoY
$-4M
Free Cash Flow
-142.0% YoY
35.3%
Gross Margin
7.5%
Op. Margin
-18.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE202.6%
ROA-13.8%
ROIC-2.1%

Valuation

P/E-8.2
P/B-9.7
EV/EBITDA972.9

Leverage

Debt/Equity-4.55
Current Ratio3.87
Interest Cov.-1.0x

Quality Scores

Piotroski F4/9
Altman Z0.19
Beneish M-2.68

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms